Neuprozyme Therapeutics Competitors and Similar CompaniesClear all

Neuprozyme Therapeutics's competitors and similar companies include Pulmotect, CalciMedica and Kamada Pharmaceuticals.
Neuprozyme Therapeutics
Neuprozyme Therapeutics
Neuprozyme Therapeutics is a company developing therapies for respiratory diseases.
Pulmotect
Pulmotect
Pulmotect is a biopharmaceutical company providing products for patients at risk of respiratory diseases.
CalciMedica
CalciMedica
CalciMedica (formerly known as Graybug Vision) is a biotechnology company that develops calcium release-activated calcium (CRAC) channel inhibitors.
Kamada Pharmaceuticals
Kamada Pharmaceuticals
Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications.
Founding Date
Founding Date
2018
Founding Date
2007
Founding Date
2007
Founding Date
1990
Type
Type
Private
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Hørsholm, DK HQ
Locations
Houston, US HQ
Locations
La Jolla, US HQ
Locations
Rehovot, IL HQ
Beit Kama, IL
Employees
Employees
N/A
Employees
10
Employees
1614% increase
Employees
420
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
42.4 m
Valuation ($)
317 m

Financial

Net income
Net income
N/A
Net income
N/A
Net income
($29.6m) (FY, 2025)
Net income
$20.2m (FY, 2025)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 11.9m
Total funding raised
$ 74.5m
Total funding raised
$ 90m
For sources of this data, please see the company profile

View Company Profiles

Pulmotect
HQ
Houston, US
Employees
10

Pulmotect is a biopharmaceutical company providing products for patients at risk of respiratory diseases.

View company
CalciMedica
HQ
La Jolla, US
Employees
16↑ 14% increase

CalciMedica (formerly known as Graybug Vision) is a biotechnology company that develops calcium release-activated calcium (CRAC) channel inhibitors.

View company
Kamada Pharmaceuticals
HQ
Rehovot, IL
Employees
420

Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications.

View company